John Glenn Iradimed Corp (IRMD) insider trading activity

John Glenn is CHIEF FINANCIAL OFFICER of IRADIMED CORP. Currently has a direct ownership of 13,151 shares of IRMD, which is worth approximately $777,487. The most recent transaction as insider was on Jun 20, 2025, when has been sold 1,412 shares (Common Stock) at a price of $58.24 per share, resulting in proceeds of $82,234. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.2K

200.05% 3M change

50.01% 12M change

Total Value Held $777,487

JOHN GLENN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2025	SELL Payment of exercise price or tax liability	$82,234 $58.24 p/Share	1,412 Reduced 9.7%	13,151 Common Stock
Jun 20 2025	BUY Exercise of conversion of derivative security	-	5,796 Added 28.47%	14,563 Common Stock
Dec 02 2024	SELL Open market or private sale	$135,450 $54.18 p/Share	2,500 Reduced 36.32%	4,383 Common Stock
Jun 20 2024	SELL Payment of exercise price or tax liability	$60,052 $42.53 p/Share	1,412 Reduced 13.87%	8,767 Common Stock
Jun 20 2024	BUY Exercise of conversion of derivative security	-	5,796 Added 36.28%	10,179 Common Stock
Jun 20 2023	SELL Payment of exercise price or tax liability	$67,606 $47.88 p/Share	1,412 Reduced 17.02%	6,883 Common Stock
Jun 20 2023	BUY Exercise of conversion of derivative security	-	5,795 Added 41.13%	8,295 Common Stock
Dec 15 2022	BUY Grant, award, or other acquisition	$71,675 $28.67 p/Share	2,500 Added 50.0%	2,500 Common Stock

Also insider at

EKSO

EKSO BIONICS HOLDINGS, INC. Healthcare

Chief Financial Officer

John Glenn

CHIEF FINANCIAL OFFICER

Richmond, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRMD shares.

Notify only if

Value

Insider Trading

Get notified when an Iradimed Corp insider buys or sells IRMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to IRADIMED CORP

Track Activities on IRMD

Account